Advanced Enzyme Technologies Ltd. Financials

NSE BSE

15:57 Aug 01

Advanced Enzyme Technologies Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology

360.35

+9.65 (+2.75%)

Sector Pharmaceuticals & Biotechnology Industry Biotechnology

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Biotechnology

360.35

+9.65 (+2.75%)
15:57 Aug 01

Quality

46/100
Medium Financial Strength

Valuation

35/100
Mid Valuation

Technical

57/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	501.84	529.38	540.64	623.87	636.91
Operating Expenses +	270.32	327.96	384.19	419.41	442.47
Raw Material	100.21	130.33	127.53	155.47	161.96
Increase Decrease in Cost	-1.16	-20.6	4.28	-10.89	-10.1
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	87.11	103.96	114.8	128.37	141.54
Miscellaneous Expenses	84.22	114.41	137.62	146.5	149.07
Operating Profit	231.52	201.42	156.45	204.46	194.44
Other Income	8.85	6.42	25.46	36.66	33.04
Depreciation	28.41	34.98	35.03	35.24	36.56
Interest	1.59	1.8	2.42	2.93	3.56
Profit before tax and exceptio..	210.37	171.06	144.45	202.95	187.36
Exceptional Items	0	0	-4.06	-15.13	0
PBT	210.37	171.06	140.39	187.82	187.36
Provision for Taxation	58.91	47.26	36.52	50.87	53.39
Net Profit	151.46	123.8	103.87	136.95	133.97
NET Profit after MI	146.2	119.58	105.64	133.3	131.12
EPS	13.07	10.68	9.45	11.92	11.72
Operating Profit Margin (%)	46.13	38.05	28.94	32.77	30.53
Net Profit Margin (%)	29.13	22.59	19.54	21.37	20.59

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	43.10	43.10	42.90	43.00	43.00
FII	23.40	11.90	12.60	12.60	12.00
MF	5.50	5.40	5.60	5.60	5.80
Others	3.00	2.80	2.50	2.40	2.30

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: